Earnings Outlook For Biora Therapeutics
Portfolio Pulse from Benzinga Insights
Biora Therapeutics (NASDAQ:BIOR) is scheduled to release its quarterly earnings report on Monday, 2023-11-13, with analysts expecting an EPS of $-0.76. Investors are looking for an earnings beat and positive guidance for the next quarter. Biora's past earnings performance shows mixed results with both beats and misses, and varied stock price reactions. Shares are currently trading at $1.49, down 79.94% over the last 52 weeks, indicating a negative sentiment among long-term shareholders ahead of the earnings release.
November 10, 2023 | 5:02 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Biora Therapeutics is expected to report an EPS of $-0.76 for the upcoming earnings. Historical data shows that stock price reactions to earnings reports can be unpredictable. With a significant 52-week decline, investor sentiment may be low.
The expected EPS of $-0.76 sets a clear benchmark for Biora Therapeutics. While past performance has shown both positive and negative reactions to earnings reports, the significant year-long decline in stock price suggests that investor sentiment is already low. The score is neutral because earnings reports can have unpredictable effects on stock prices, and the article does not provide sufficient data to forecast a direction.
CONFIDENCE 70
IMPORTANCE 80
RELEVANCE 100